Drug Increases Energy Expenditure Through Unexpected Metabolic Mechanism

A small human study found that the drug fenoterol increased calorie burning without clearly activating brown adipose tissue, the heat-producing tissue researchers expected to be responsible. The compound stimulates beta2 adrenergic receptors and was designed to mimic the metabolic effects of cold exposure, but the mechanism by which it boosted energy expenditure remains unclear. Researchers hope to better understand brown fat regulation to develop more effective weight management therapies that combine appetite suppression with increased energy use.

Researchers have long pursued pharmaceutical approaches to activate brown adipose tissue because of its natural thermogenic properties—the tissue's ability to generate heat and expend energy distinguishes it from white fat, which primarily stores calories. Cold exposure reliably triggers this response, and individuals with higher brown fat activity typically maintain healthier body weights and metabolic markers. This observation has motivated scientists to develop drugs that replicate cold's effects without requiring patients to endure uncomfortable temperatures.

The unexpected finding that fenoterol boosted calorie burning through an unknown mechanism suggests brown fat activation may be more complex than a single receptor pathway. The researchers propose that skeletal muscle or white adipose tissue could account for the increased energy expenditure, indicating multiple biological systems may need simultaneous activation. This complexity could reshape therapeutic strategies, potentially requiring combination approaches rather than targeting brown fat alone.